Homocysteine and cardiovascular disease: Current evidence and future prospects

A A Mangoni, S H D Jackson

Research output: Contribution to journalLiterature reviewpeer-review

208 Citations (Scopus)


Hyperhomocysteinemia is an independent risk factor for cardiovascular disease, Despite the well-known effectiveness of vitamin supplementation in reducing homocysteine levels, it is not known whether lowering of homocysteine levels is associated with a reduction in cardiovascular morbidity and mortality. The aim of this review is to discuss the epidemiologic evidence about the relation between homocysteine and cardiovascular disease, the pathophysiologic mechanisms responsible for the deleterious vascular and hemostatic effects of homocysteine, and studies of the potential benefits of homocysteine-lowering therapy.
Original languageEnglish
Pages (from-to)556 - 565
Number of pages10
JournalAmerican Journal of Medicine
Issue number7
Publication statusPublished - 2002


Dive into the research topics of 'Homocysteine and cardiovascular disease: Current evidence and future prospects'. Together they form a unique fingerprint.

Cite this